Search

New MSK research reveals how dormant metastatic cancer cells protect themselves from the immune system by changing their shape.

… Thursday, January 15, 2026 Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune defenders and biding their time until conditions are ripe for establishing a new tumor elsewhere in the body, a process known as metastasis. The vast majority

Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research.

… Thursday, April 10, 2014 Summary Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research. Two Memorial Sloan Kettering studies about targeted cancer therapies received recognition in the press program for one of the nation

Tobias M. Hohl, MD, PhD, Chief of the Infectious Diseases Service in the Department of Medicine, was elected a 2022 Fellow of the American Association for the Advancement of Science (AAAS), the world’s largest scientific society and publisher of the Science journals. This title is one of the most distinguished honors within the scientific community and is designed to recognize leaders for their notable contributions to science.

… Friday, February 3, 2023 Tobias M. Hohl, MD, PhD , Chief of the Infectious Diseases Service in the Department of Medicine, was elected a 2022 Fellow of the American Association for the Advancement of Science  (AAAS), the world’s largest scientific society and publisher of the  Science journals. This

Read a letter from Memorial Sloan Kettering's leadership team about our commitment to our community in response to acts of racism and discrimination.

… Tuesday, June 2, 2020 We are deeply saddened by the senseless and devastating acts of racism and discrimination occurring across the country. They have no place in our communities or workplaces. It rests in our hands to do what is right, to work together to fight injustice and to be part of the solution

… Tuesday, July 1, 2014 Memorial Sloan Kettering pharmacologist Gavril Pasternak has been named a 2014 Harrington Scholar-Innovator for his work in developing a class of analgesics more potent than morphine but free from the negative side effects and potential for abuse associated with traditional opioids

Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer.

… Thursday, March 12, 2015 Summary Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer. Starting in the mid-1990s, while he was at the University of California, Los Angeles , Memorial Sloan Kettering physician-scientist

New data presented today by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after surgery.

… Sunday, April 7, 2024 New data presented today by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate

The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail.

… Friday, June 27, 2014 Summary The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail. Memorial Sloan Kettering has taken a leap into the future with the launch of a new cyclotron, a type

Read about Ashley Landay, a breast cancer patient at MSK, who will run the TCS New York City Marathon with her chemotherapy nurse, Ashley Pildis.

… Thursday, October 31, 2019 Pictured: Ashley Landay (left) and Ashley Pildis (right) For the second year, MSK patient Ashley Landay (left) and her chemotherapy nurse Ashley Pildis (right) will run the TCS New York City Marathon together for Fred's Team, which raises funds for cancer research at Memorial

Comedy vs Cancer, a night of humor and hope to outwit blood cancers, raised $1.2 million for research at MSK. There were a thousand people in the audience in New York City on Thursday, April 20, 2023, at Jazz at Lincoln Center’s Frederick P. Rose Hall.

… Tuesday, April 25, 2023 Comedy vs Cancer , a night of humor and hope to outwit blood cancers, raised $1.2 million for research at Memorial Sloan Kettering Cancer Center (MSK). There were a thousand people in the audience in New York City on Thursday, April 20, 2023, at Jazz at Lincoln Center’s Frederick